Dr Camilla Nord
University of Cambridge
Dr Camilla Nord is a neuroscientist and MRC Investigator Scientist at the University of Cambridge, MRC Cognition and Brain Sciences Unit. After completing an undergraduate degree in Physiology, Psychology, and Philosophy at Magdalen College, Oxford, she undertook a PhD at University College London with Prof. Jonathan Roiser on the role of dorsolateral prefrontal cortex dysfunction in depression. Her key interests are in uncovering cognitive and neural mechanisms common across different neuropsychiatric disorders and testing whether any of these mechanisms could serve as “biomarkers” that might help us predict response to different treatments.
Neurobiological predictors of response to tDCS-enhanced psychological therapy in depression
We conducted a randomised controlled trial to test whether transcranial direct current stimulation (tDCS) would enhance clinical response to cognitive behavioural therapy in depression. We showed a 20% improvement of real over sham tDCS, which was not significant. However, we found that baseline dorsolateral prefrontal cortex activation was specifically associated with response to tDCS. This could potentially have use as a “biomarker” identifying patients who might respond to tDCS.
EVEN MORE SEMINARS
Dr Srinivas Lanka Cygnet Health Care
Measuring Outcomes in Neuropsychiatry
Kayleigh Wain Priory Healthcare
Communication and Swallowing Disorders common in Acquired Brain Injury
Prof. Ioannis Patrikios
Chairman of the School of Medicine
European University Cyprus Aniva International S.A.
Specific Structured Nutritional Molecules as Strong Antiinflammatory Agents for Neuro-degenerative Diseases: True or False
NECHAMA KARMAN MOBILITY RESEARCH UK
Braking Bad: Developing Eccentric Control in Clients with CNS Dysfunction
Dr Vijay Palanivel The Children’s Trust
Paediatric brain injury: outcomes and predictors of long-term prognosis